Related Experiment Videos

A case-control study of determinants for the occurrence of gouty arthritis in heart failure patients

Berdine A A Hueskes1, Frank F Willems, Aukelien C Leen

  • 1Department of Rheumatology, Rijnstate, 6883 AZ Velp, The Netherlands.

European Journal of Heart Failure
|June 23, 2012
PubMed

Insights

Heart failure patients with hypertensive heart failure, advanced NYHA class, lower GFR, and low FEUA are at higher risk for gouty arthritis. Spironolactone use may decrease gout risk in these patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Nephrology

Background:

  • Gouty arthritis is a common and debilitating condition in patients with heart failure.
  • Identifying risk factors for gouty arthritis in heart failure patients is crucial for improving their quality of life.

Purpose of the Study:

  • To investigate factors associated with the occurrence of gouty arthritis in heart failure patients.
  • To identify potential preventative strategies for gouty arthritis in this population.

Main Methods:

  • A case-control study involving 188 heart failure patients (59 with gouty arthritis) was conducted.
  • Evaluated factors included echocardiographic dimensions, laboratory values (GFR, FEUA), and medication use (spironolactone).
  • Logistic regression analysis was used to determine odds ratios (ORs) and 95% confidence intervals (CIs).

Main Results:

  • Spironolactone use was associated with a decreased occurrence of gouty arthritis (OR 0.32).
  • Hypertensive heart failure (OR 3.6), NYHA class III/IV (OR 4.5), lower GFR, and FEUA <4% (OR 3.3) were independently associated with increased gouty arthritis.
  • The strongest association was observed in men under 65 years.

Conclusions:

  • Identification of these factors enables the development of targeted strategies to enhance the quality of life for heart failure patients.
  • Prospective studies are needed to confirm the potential protective effect of spironolactone against gouty arthritis.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...